HIGHLIGHTS
- who: Abrar I. Aljohani from the Academic Unit for Translational Medical Sciences, School of Medicine, Nottingham Breast Cancer Research Centre, University of Nottingham Biodiscovery Institute, University Park, Nottingham , RD, UK have published the article: The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development, in the Journal: (JOURNAL)
- what: The authors aimed to assess the association between and other clinicopathological and other LVI-related biomarkers at the molecular (RNA transcriptomic) and proteomic levels in BC. In regard to the patients` cohort used in this study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.